Add to ORKGAims/hypothesis Observational and mechanistic studies have suggested a possible relationship between treatment with metformin and decreased incidence of cancer in participants with type 2 diabetes. We extracted data for malignancies from the ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluate
D iabetes is associated with an in-creased risk of various forms ofcancer, such as cancer of the liv...
BackgroundRecently, several studies reported that the cancer incidence in type 2 diabetes patients i...
OBJECTIVEdType 2 diabetes is associated with an increased risk of several types of cancer and with r...
Aim: To assess the effect of metformin on cancer incidence in type 2 diabetes (T2DM), considering po...
OBJECTIVE - Several Studies have suggested an association between specific diabetes treatment and ca...
Aims/Hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer...
AIMS/HYPOTHESIS: Diabetes treatments were related with either an increased or reduced risk of cancer...
Aims/Hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer...
A long term complication of diabetes is the increased susceptibility to develop various malignancies...
Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in epidemiologi...
OBJECTIVE — The antidiabetic properties of metformin are mediated through its ability to activate th...
OBJECTIVE - The antidiabetic properties of metformin are mediated through its ability to activate th...
OBJECTIVEdObservational studies have associated metformin use with a decreased risk of lung cancer i...
Diabetes may be a risk factor for cancer and is associated with worse cancer outcomes. Metformin may...
Patients with diabetes mellitus are at increased risk of cancer development. Metformin is a well-est...
D iabetes is associated with an in-creased risk of various forms ofcancer, such as cancer of the liv...
BackgroundRecently, several studies reported that the cancer incidence in type 2 diabetes patients i...
OBJECTIVEdType 2 diabetes is associated with an increased risk of several types of cancer and with r...
Aim: To assess the effect of metformin on cancer incidence in type 2 diabetes (T2DM), considering po...
OBJECTIVE - Several Studies have suggested an association between specific diabetes treatment and ca...
Aims/Hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer...
AIMS/HYPOTHESIS: Diabetes treatments were related with either an increased or reduced risk of cancer...
Aims/Hypothesis: Diabetes treatments were related with either an increased or reduced risk of cancer...
A long term complication of diabetes is the increased susceptibility to develop various malignancies...
Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in epidemiologi...
OBJECTIVE — The antidiabetic properties of metformin are mediated through its ability to activate th...
OBJECTIVE - The antidiabetic properties of metformin are mediated through its ability to activate th...
OBJECTIVEdObservational studies have associated metformin use with a decreased risk of lung cancer i...
Diabetes may be a risk factor for cancer and is associated with worse cancer outcomes. Metformin may...
Patients with diabetes mellitus are at increased risk of cancer development. Metformin is a well-est...
D iabetes is associated with an in-creased risk of various forms ofcancer, such as cancer of the liv...
BackgroundRecently, several studies reported that the cancer incidence in type 2 diabetes patients i...
OBJECTIVEdType 2 diabetes is associated with an increased risk of several types of cancer and with r...